Public Citizen Calls Out Pfizer’s “Patent Wall” for COVID-19 Treatment
Public Citizen has released a statement accusing Pfizer of filing a barrage of patents for a key component of their [...]
Safety and Efficacy of Brolucizumab in DME Backed by 3 Studies
Three recent clinical trials have found Brolucizumab 6 mg to have a positive benefit-risk ratio for treating diabetic macular edema. [...]
Lancet Neurology Study Finds Riluzole Ineffective for SCA2
Riluzole was not found to improve patient outcomes living with spinocerebellar ataxia type 2 in a study published in the [...]
Opioid Manufacturer Teva Reaches $225 Million Settlement Deal with State of Texas
The drug manufacturer Teva Pharmaceutical Industries LLC has settled a lawsuit levied against them from the state of Texas for [...]
Study Finds that Rheumatologists’ Prescribing Habits Influenced by Pharma Payments for Food and Drink
A new study in Mayo Clinic Proceedings found that payments for food and drinks from drug companies were associated with [...]
Cardinal Health Case Study: Using Real-World Evidence to Expedite Regulatory Approval
When seeking expedited regulatory approval, biopharmaceutical companies need authoritative real-world evidence (RWE) to make their case. In a new case [...]
Robert Califf Confirmed as FDA Commissioner
In a narrow 50-46 vote, Robert Califf has officially been confirmed as the Food and Drug Administrations new commissioner. This [...]
Final Vote on Califf for FDA Commissioner
The Senate votes on the confirmation of Robert Califf for FDA Commissioner today amid ongoing political turmoil. Although largely divided [...]
ICER: Final Evidence Report and Policy Recommendations on Tirzepatide Now Available
The Institute for Clinical and Economic Review (ICER) just released their final evidence report on the diabetes 2 drug terzepatide. [...]
FTC to Vote on Investigating Pharmacy Benefit Manager Practices
The US Federal Trade Commission (FTC) will vote on whether to examine the impact of pharmacy benefit managers (PBM) on [...]
Swiss Voters Stop Proposed Animal Testing Ban
A campaign in Switzerland that would ban all animal testing failed to pass this weekend earning only 21% of the [...]
MAPS Leadership Perspective: Impact of Digital on Healthcare
In the latest installment of the Medical Affairs Professional Society’s (MAPS) Perspectives series, John Pracyk, MD, PhD, MBA, talks with [...]
ICR: NICE Reforms Fall Short of Increasing Access to Innovative Cancer Treatments
The Institute of Cancer Research (ICR), London, is not satisfied with The National Institute of Health and Care Excellence’s (NICE) [...]
Payers – Three Upcoming Drugs to Watch
OptumRX has released its quarterly pharmacy benefit manager’s quarterly drug pipeline report. The report focuses on three upcoming drugs that [...]
Webinar: Health and Private Equity in 2022
Private equity is a growing force in healthcare, with companies always searching for promising organizations and market sectors. As a [...]
AbbVie’s Claims of Corporate Espionage will be Investigated by US International Trade Commission
The US International Trade Commission has announced they will investigate claims that two companies planning to release a biosimilar of [...]
Reuters white paper: Building a Framework for Decentralized Clinical Trials in a Hybrid Future
The future of clinical trials is moving towards a field with decentralized, site-based, and hybrid trials that combine elements of [...]
Value Special Pharmacy Implements Inovalon’s ScriptMed Cloud
Inovalon has entered into a deal with Value Special Pharmacy to provide its Inovalon ONE® Platform to the company. Value [...]
2021 CDER Report: New Approvals Improve Patient Treatment Options
The Center for Drug Evaluation and Research (CDER) has released a new report detailing the 60 drugs the FDA approved [...]
Congress Pursuing Price Setting Measures that May Not Benefit Patients
In a new PhRMA article, Nicole Longo argues that Congress is starting off the year on a wrong foot with [...]
Michigan Attorney General Seeks Investigation Regarding Eli Lilly’s Exorbitant Insulin Prices
The Michigan Attorney General has asked the courts to approve a formal investigation into Eli Lilly’s excessive insulin prices. The [...]
Biden Administration Spent Billions of Hospital Covid-19 Funding on Vaccines and Therapeutics
In a move mirroring the Trump administration, the Biden Administration diverted almost $7 billion that was initially allocated to hospitals [...]
States Can Help Lower Medicine Costs for Patients
Medicine costs for patients have spiked in the past few years, especially for patients with deductibles who often pay the [...]
Infographic: The Power of the Digital Thread in Life Sciences
A new infographic shows how the digital thread can empower life sciences product development. The digital thread unifies product design, [...]
ICER Releases Draft Report on Plinabulin and Trilaciclib for Chemo-induced Neutropenia
The Institute for Clinical and Economic Review (ICER) has released its draft evidence report for the novel drugs plinabulin (BeyondSpring [...]